Relebactam is a diazabicyclooctane beta-lactamase inhibitor, structurally similar to avibactam, and serves as an active pharmaceutical ingredient used in combination with imipenem and cilastatin. It features a piperidine ring that imparts a positive charge, reducing bacterial export, and was approved by the FDA in 2019 as part of the Recarbrio® combination product for treating complicated urinary tract infections, pyelonephritis, and complicated intra-abdominal infections in adults.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1174018-99-5
Relebactam
beta-lactamase inhibitor
Potassium clavulanate
beta-lactamase inhibitor active pharmaceutical ingredient
Cefditoren pivoxil
prodrug antibacterial active pharmaceutical ingredient
Calcium dobesilate monohydrate
Vasoprotective agent
Desethanol Dipyridamole
active pharmaceutical ingredient impurity
Desosaminylazithromycin
antibiotic pharmaceutical intermediate
1,1-Dimethylethyl 4-[[[(1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]oct-2-yl]carbonyl]amino]-1-piperidinecarboxylate
research compound
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
SMOBCLHAZXOKDQ-ZJUUUORDSA-N
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3